{
  "@context": "https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld",
  "@id": "https://druglandscape.com/data.json",
  "@type": "dcat:Catalog",
  "conformsTo": "https://project-open-data.cio.gov/v1.1/schema",
  "describedBy": "https://project-open-data.cio.gov/v1.1/schema/catalog.json",
  "dataset": [
    {
      "@type": "dcat:Dataset",
      "title": "2026 FDA Drug Approvals",
      "description": "Comprehensive 2026 FDA approvals dataset covering new molecular entities (NMEs), supplemental new drug applications (sNDAs), supplemental biologics license applications (sBLAs), and biosimilar approvals. Sourced from Drugs@FDA daily, cross-referenced with FDA Advisory Committee briefing documents and sponsor 8-K filings.",
      "identifier": "druglandscape:fda-approvals-2026",
      "landingPage": "https://druglandscape.com/datasets/fda-approvals-2026",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "FDA",
        "drug approval",
        "NDA",
        "BLA",
        "NME",
        "biosimilar",
        "pharmaceutical regulation",
        "2026"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1D",
      "temporal": "2026-01-01/2026-12-31",
      "spatial": "United States",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/fda-approvals-2026.csv",
          "mediaType": "text/csv",
          "title": "2026 FDA Drug Approvals (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/fda-approvals-2026.json",
          "mediaType": "application/json",
          "title": "2026 FDA Drug Approvals (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2025 FDA Drug Approvals",
      "description": "Historical dataset of 2025 FDA approvals — NMEs, sNDAs, sBLAs, and biosimilars. Final retrospective version published Q1 2026 after all 2025 PDUFA windows closed.",
      "identifier": "druglandscape:fda-approvals-2025",
      "landingPage": "https://druglandscape.com/datasets/fda-approvals-2025",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "FDA",
        "drug approval",
        "2025",
        "historical",
        "NME",
        "biosimilar"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1M",
      "temporal": "2025-01-01/2025-12-31",
      "spatial": "United States",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/fda-approvals-2025.csv",
          "mediaType": "text/csv",
          "title": "2025 FDA Drug Approvals (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/fda-approvals-2025.json",
          "mediaType": "application/json",
          "title": "2025 FDA Drug Approvals (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2026 Pharmaceutical Patent Cliff",
      "description": "The complete 2026 patent cliff — every Orange Book listed patent and USPTO drug-related patent reaching its listed expiry date in 2026, joined to the branded drug it protects, its annual revenue (where disclosed), and the projected generic / biosimilar entry timing.",
      "identifier": "druglandscape:patent-expiries-2026",
      "landingPage": "https://druglandscape.com/datasets/patent-expiries-2026",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "patent cliff",
        "patent expiry",
        "generic entry",
        "biosimilar entry",
        "Orange Book",
        "USPTO",
        "2026"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1W",
      "temporal": "2026-01-01/2026-12-31",
      "spatial": "United States",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2026.csv",
          "mediaType": "text/csv",
          "title": "2026 Pharmaceutical Patent Cliff (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2026.json",
          "mediaType": "application/json",
          "title": "2026 Pharmaceutical Patent Cliff (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2027 Pharmaceutical Patent Cliff",
      "description": "2027 forward-looking patent cliff dataset.",
      "identifier": "druglandscape:patent-expiries-2027",
      "landingPage": "https://druglandscape.com/datasets/patent-expiries-2027",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "patent cliff",
        "2027",
        "Orange Book",
        "USPTO",
        "generic entry"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1W",
      "temporal": "2027-01-01/2027-12-31",
      "spatial": "United States",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2027.csv",
          "mediaType": "text/csv",
          "title": "2027 Pharmaceutical Patent Cliff (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2027.json",
          "mediaType": "application/json",
          "title": "2027 Pharmaceutical Patent Cliff (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2028 Pharmaceutical Patent Cliff",
      "description": "2028 forward-looking patent cliff dataset.",
      "identifier": "druglandscape:patent-expiries-2028",
      "landingPage": "https://druglandscape.com/datasets/patent-expiries-2028",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "patent cliff",
        "2028",
        "Orange Book",
        "USPTO"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1W",
      "temporal": "2028-01-01/2028-12-31",
      "spatial": "United States",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2028.csv",
          "mediaType": "text/csv",
          "title": "2028 Pharmaceutical Patent Cliff (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/patent-expiries-2028.json",
          "mediaType": "application/json",
          "title": "2028 Pharmaceutical Patent Cliff (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2026 Pivotal Phase 3 Readout Calendar",
      "description": "All Phase 3 trials registered on ClinicalTrials.gov with a primary completion date in calendar year 2026. Includes sponsor, drug, indication, sample size, primary endpoint, and any posted preliminary results.",
      "identifier": "druglandscape:phase-3-readouts-2026",
      "landingPage": "https://druglandscape.com/datasets/phase-3-readouts-2026",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "clinical trial",
        "Phase 3",
        "readout",
        "pivotal trial",
        "primary completion",
        "2026"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1W",
      "temporal": "2026-01-01/2026-12-31",
      "spatial": "Worldwide",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/phase-3-readouts-2026.csv",
          "mediaType": "text/csv",
          "title": "2026 Pivotal Phase 3 Readout Calendar (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/phase-3-readouts-2026.json",
          "mediaType": "application/json",
          "title": "2026 Pivotal Phase 3 Readout Calendar (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "2027 Pivotal Phase 3 Readout Calendar",
      "description": "Forward-looking 2027 Phase 3 readout calendar.",
      "identifier": "druglandscape:phase-3-readouts-2027",
      "landingPage": "https://druglandscape.com/datasets/phase-3-readouts-2027",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "clinical trial",
        "Phase 3",
        "2027",
        "readout"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P1W",
      "temporal": "2027-01-01/2027-12-31",
      "spatial": "Worldwide",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/phase-3-readouts-2027.csv",
          "mediaType": "text/csv",
          "title": "2027 Pivotal Phase 3 Readout Calendar (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/phase-3-readouts-2027.json",
          "mediaType": "application/json",
          "title": "2027 Pivotal Phase 3 Readout Calendar (JSON)"
        }
      ]
    },
    {
      "@type": "dcat:Dataset",
      "title": "Pharmaceutical Blockbusters ($1B+ annual revenue)",
      "description": "All currently-marketed drugs with disclosed annual revenue above $1 billion, sourced from quarterly SEC filings (10-K, 10-Q) and equivalent international filings.",
      "identifier": "druglandscape:blockbusters",
      "landingPage": "https://druglandscape.com/datasets/blockbusters",
      "accessLevel": "public",
      "license": "https://druglandscape.com/editorial-policy",
      "publisher": {
        "@type": "org:Organization",
        "name": "Drug Landscape"
      },
      "keyword": [
        "blockbuster drug",
        "pharmaceutical revenue",
        "top selling drug",
        "SEC filing"
      ],
      "modified": "2026-06-10",
      "issued": "2026-01-15",
      "accrualPeriodicity": "R/P3M",
      "spatial": "Worldwide",
      "contactPoint": {
        "@type": "vcard:Contact",
        "fn": "Drug Landscape",
        "hasEmail": "mailto:hello@druglandscape.com"
      },
      "distribution": [
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/blockbusters.csv",
          "mediaType": "text/csv",
          "title": "Pharmaceutical Blockbusters ($1B+ annual revenue) (CSV)"
        },
        {
          "@type": "dcat:Distribution",
          "downloadURL": "https://druglandscape.com/data/blockbusters.json",
          "mediaType": "application/json",
          "title": "Pharmaceutical Blockbusters ($1B+ annual revenue) (JSON)"
        }
      ]
    }
  ]
}